Mohammed H. Jarrar, Ph.D. - Publications

Affiliations: 
2008 George Mason University, Washington, DC 
Area:
Molecular Biology, Pathology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Jarrar M. The Bridge between Obesity and Non-Communicable Diseases Strengthen By Oxidative Stress and Inflammation: Unconventional Systematic Measures Needed To Abate These Health Disorders Journal of Obesity and Weight Loss Therapy. 8: 1-1. DOI: 10.4172/2165-7904.1000E120  0.312
2017 Jarrar M, El-Shafey A. The Paradox of Ectopic Melanin Synthesis in Adipose: Potential Mechanism, Benefits and Perspectives in Abating Obesity Complications Journal of Obesity and Weight Loss Therapy. 8: 1-8. DOI: 10.4172/2165-7904.1000363  0.372
2016 Jarrar M, Behl S, Manyam G, Ganah H, Nazir M, Nasab R, Moustafa K. Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy. Molecular Biology Reports. PMID 27072373 DOI: 10.1007/S11033-016-3983-1  0.565
2013 Birerdinc A, Jarrar M, Stotish T, Randhawa M, Baranova A. Manipulating molecular switches in brown adipocytes and their precursors: a therapeutic potential. Progress in Lipid Research. 52: 51-61. PMID 22960032 DOI: 10.1016/J.Plipres.2012.08.001  0.663
2011 Estep M, Abawi M, Jarrar M, Wang L, Stepanova M, Elariny H, Moazez A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obesity Surgery. 21: 1750-7. PMID 21744131 DOI: 10.1007/S11695-011-0475-1  0.649
2011 Baranova A, Jarrar MH, Stepanova M, Johnson A, Rafiq N, Gramlich T, Chandhoke V, Younossi ZM. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C. Digestion. 83: 32-40. PMID 20847561 DOI: 10.1159/000314592  0.515
2011 Baranova A, Jarrar M, Abawi M, Wang L, Afendy A, Stepanova M, Estep JM, Moazzez AH, Goodman Z, Chandhoke V, Younossi ZM. Soluble Molecules Released From Visceral Adipose Tissue May Contribute to the Development of Advanced Non-Alcoholic Fatty Liver Disease Gastroenterology. 140: S-701. DOI: 10.1016/S0016-5085(11)62914-4  0.728
2009 Lim HM, Kim ER, Kim JY, Chang DK, Son HJ, Rhee P, Kim JJ, Rhee JC, Kim Y, Nass FR, Kotze LMdS, Biecker E, Hausdörfer I, Grünhage F, Strunk H, ... ... Jarrar MH, et al. JGA Society News Digestion. 80: 136-136. DOI: 10.1159/000232948  0.422
2008 Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obesity Surgery. 18: 1430-7. PMID 18500507 DOI: 10.1007/S11695-008-9506-Y  0.737
2008 Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Adipokines and cytokines in non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 27: 412-21. PMID 18081738 DOI: 10.1111/J.1365-2036.2007.03586.X  0.638
2008 Younossi Z, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Afendy A, Rafiq N, Goodman Z, Chandhoke V, Baranova A. 31 VALIDATION OF A DIAGNOSTIC BIOMARKER PANEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) Journal of Hepatology. 48: S14-S15. DOI: 10.1016/S0168-8278(08)60033-1  0.696
2007 Baranova A, Schlauch K, Elariny H, Jarrar M, Bennett C, Nugent C, Gowder SJ, Younoszai Z, Collantes R, Chandhoke V, Younossi ZM. Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. Obesity Surgery. 17: 1111-8. PMID 17953248 DOI: 10.1007/S11695-007-9187-Y  0.667
2007 Jarrar MH, Baranova A. PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. Journal of Cellular and Molecular Medicine. 11: 71-87. PMID 17367502 DOI: 10.1111/J.1582-4934.2007.00003.X  0.484
2007 Baranova A, Randhawa M, Jarrar M, Younossi ZM. Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease. Expert Review of Molecular Diagnostics. 7: 195-205. PMID 17331066 DOI: 10.1586/14737159.7.2.195  0.735
2007 Jarrar M, Ranard B, Stepanova M, Nugent C, Elariny H, Bennett C, Collantes R, Goodman Z, Chandhoke V, Baranova A, Younossi Z. [718] HEPATIC MANIFESTATION OF METABOLIC SYNDROME (MS): NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SERUM ADIPOKINES Journal of Hepatology. 46: S271. DOI: 10.1016/S0168-8278(07)62316-2  0.635
2006 Baranova A, Gowder S, Naouar S, King S, Schlauch K, Jarrar M, Ding Y, Cook B, Chandhoke V, Christensen A. Expression profile of ovarian tumors: distinct signature of Sertoli-Leydig cell tumor. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 1963-72. PMID 17177833 DOI: 10.1111/J.1525-1438.2006.00732.X  0.471
Show low-probability matches.